Virpax Pharmaceuticals Inc Stock price
Is Virpax Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Virpax Pharmaceuticals Inc Stock Analysis
Analyst Opinions
6 Analysts have issued a Virpax Pharmaceuticals Inc forecast:
Analyst Opinions
6 Analysts have issued a Virpax Pharmaceuticals Inc forecast:
Don't miss a Thing! We will send you all news about Virpax Pharmaceuticals Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
| Head office | United States |
| CEO | Mr. Dhaliwal |
| Employees | 2 |
| Founded | 2016 |
| Website | virpaxpharma.com |


